Stay updated on TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial
Sign up to get notified when there's something new on the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page.

Latest updates to the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page
- Check5 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No study details or essential page content appear to be affected.SummaryDifference0.2%

- Check13 days agoChange DetectedLatest version updates core study information, including recruitment status and study description. It also adjusts listed locations and contact details.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new site release, Revision: v3.4.2, was added. The lapse in government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.6%

- Check41 days agoChange DetectedAdded a site-wide funding notice and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedAdded a glossary toggle and color-coded change highlights (green/red) with a new revision label (v3.4.0); capitalization tweaks to the No FEAR Act data label.SummaryDifference0.8%

- Check84 days agoChange DetectedFooter updates: added revision note v3.3.3 and removed HHS Vulnerability Disclosure and revision note v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page.